Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weliplex S is a homeopathic complex preparation developed by Weber & Weber Biologische Arzneimittel, specifically indicated for the relief of hay fever (allergic rhinitis) symptoms. The formulation consists of six active homeopathic ingredients: Aralia racemosa, Arsenum iodatum, Cardiospermum halicacabum, Galphimia glauca, Luffa operculata, and Okoubaka aubrevillei. These components are selected based on homeopathic provings to address various manifestations of allergic reactions, such as sneezing, nasal discharge, and mucosal inflammation. As a natural medicine, it aims to provide a therapeutic effect through the principle of "like cures like," utilizing highly diluted substances to trigger the body's regulatory mechanisms without the sedative side effects common in conventional antihistamines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Weliplex S.